Literature DB >> 27900565

Randomized double-blind controlled clinical trials with herbal preparations of Serenoa repens fruits in treatment of lower urinary tract symptoms : An overview.

Rainer C Görne1,2,3, Tankred Wegener4,5, Olaf Kelber4,6, Björn Feistel4,7, Jürgen Reichling4,8.   

Abstract

In this review, results of randomized double-blind controlled clinical trials (RCTs) with extracts of Serenoa repens fruits at a dose of 320 mg/d for the treatment of lower urinary tract symptoms (LUTS) are assessed. Of the RTCs conducted for up to 6 months, a benefit was seen in three of three RTCs with ethanolic, in eight of nine RTCs with hexane, and in one of two RTCs with CO2 extracts. Of the RTCs conducted for more than 6 months, a benefit was seen in two RTCs with hexane and in one RTC with CO2 extracts, whereas one RTC with an ethanolic, two RTCs with hexane, and one RTC with CO2 extracts did not show positive results. As LUTS are dynamic conditions with strong spontaneous fluctuation over time, the majority of patients might expect improvement of single symptoms and thus of quality of life, particularly as the extracts are well tolerated even in long-term treatment.

Entities:  

Keywords:  Ethanolic extract; Hexane extract; Long-term treatment; Saw palmetto fruits; Systematic review

Mesh:

Substances:

Year:  2016        PMID: 27900565     DOI: 10.1007/s10354-016-0526-2

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  28 in total

1.  Efficacy and tolerability of the lipidosterolic extract of Serenoa repens (Permixon) in benign prostatic hyperplasia: a double-blind comparison of two dosage regimens.

Authors:  V N Stepanov; L A Siniakova; B Sarrazin; J P Raynaud
Journal:  Adv Ther       Date:  1999 Sep-Oct       Impact factor: 3.845

2.  Does the addition of Serenoa repens to tamsulosin improve its therapeutical efficacy in benign prostatic hyperplasia?

Authors:  Aleksandar Argirović; Djordje Argirović
Journal:  Vojnosanit Pregl       Date:  2013-12       Impact factor: 0.168

Review 3.  [Primary and secondary prevention of benign prostatic hyperplasia: current knowledge and implications for clinical management].

Authors:  M Oelke; S Madersbacher
Journal:  Urologe A       Date:  2011-10       Impact factor: 0.639

4.  Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms.

Authors:  G S Gerber; D Kuznetsov; B C Johnson; J D Burstein
Journal:  Urology       Date:  2001-12       Impact factor: 2.649

5.  A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia.

Authors:  G Champault; J C Patel; A M Bonnard
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

6.  [Phytotherapy of benign prostate syndrome and prostate cancer: better than placebo].

Authors:  C Wehrberger; K Dreikorn; B J Schmitz-Dräger; M Oelke; S Madersbacher
Journal:  Urologe A       Date:  2012-12       Impact factor: 0.639

7.  Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial.

Authors:  K E Willetts; M S Clements; S Champion; S Ehsman; J A Eden
Journal:  BJU Int       Date:  2003-08       Impact factor: 5.588

Review 8.  A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting.

Authors:  M T Rosenberg; D R Staskin; S A Kaplan; S A MacDiarmid; D K Newman; D A Ohl
Journal:  Int J Clin Pract       Date:  2007-07-11       Impact factor: 2.503

9.  [Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study].

Authors:  Frans Debruyne; Gary Koch; Peter Boyle; Fernando Calais Da Silva; Jay G Gillenwater; Freddie C Hamdy; Paul Perrin; Pierre Teillac; Remigio Vela-Navarrete; Jean-Pierre Raynaud
Journal:  Prog Urol       Date:  2002-06       Impact factor: 0.915

10.  [Benign prostate hyperplasia: success and limitations of pharmacological therapy].

Authors:  S Madersbacher; M Marszalek
Journal:  Internist (Berl)       Date:  2007-10       Impact factor: 0.743

View more
  1 in total

1.  Complementary therapies in the control of male lower urinary tract symptoms: A systematic review.

Authors:  Luciana Regina Ferreira da Mata; Paula Giuliana Rodrigues Motter; Cissa Azevedo; Mariana Ferreira Vaz Gontijo Bernardes; Tânia Couto Machado Chianca; Christiane Inocêncio Vasques
Journal:  Rev Lat Am Enfermagem       Date:  2022-07-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.